Posted in | News | Iron Ore

Champion Minerals Reports New Assay Results from Fancamp's Moire Lake Project

Fancamp Exploration has announced that Champion Minerals has reported the new assay results from its Moire Lake project, in which Fancamp has 17.5% interest.

The strategic location of the project is directly to the eastern part of and adjacent to the Mont Wright mine property of ArcelorMittal and is also 8 km to the southern side of the present rail transport infrastructure.

The company has cut 31.2% total iron (FeT) over 503.4 m in the hole LM11-12 at the southeast of the significant Lac Moire. It has intersected 27.6% FeT over 390.1 m and 31.5% FeT over 237.1 m in the hole LM11-16, which is situated around 400 m to the northeast part and along the strike of the hole LM11-12, and 30.3% FeT over 383.4 m in the hole LM11-09, which is situated about 400 m to the northeast of the drill hole LM11-16. The company has outlined these three drill holes for around 1 km of iron structure along the strike, with 383 m to 503 m of down-hole cuts and these holes have validated the iron-rich Sokoman structure continuity that is around the widened southeast fold closure.

The CEO and President of Champion, has stated that the 2011 new drilling results from the Moire Lake have additionally validated the continuity of the high-grade of the iron structures occurring on the property that is well situated in the Labrador trough. The assay results combined with the widths from Moire Lake are extensive and it is anticipated that the latest resource estimate will discover a considerable increase in the past resource.

The operator of the Moire Lake project is Champion Minerals and work is ongoing to additionally develop the project. Fancamp has planned to continue its proportional interest in this project and the additional properties in the Joint Venture.

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Fancamp Exploration Ltd. (2019, February 18). Champion Minerals Reports New Assay Results from Fancamp's Moire Lake Project. AZoMining. Retrieved on November 21, 2024 from https://www.azomining.com/News.aspx?newsID=5097.

  • MLA

    Fancamp Exploration Ltd. "Champion Minerals Reports New Assay Results from Fancamp's Moire Lake Project". AZoMining. 21 November 2024. <https://www.azomining.com/News.aspx?newsID=5097>.

  • Chicago

    Fancamp Exploration Ltd. "Champion Minerals Reports New Assay Results from Fancamp's Moire Lake Project". AZoMining. https://www.azomining.com/News.aspx?newsID=5097. (accessed November 21, 2024).

  • Harvard

    Fancamp Exploration Ltd. 2019. Champion Minerals Reports New Assay Results from Fancamp's Moire Lake Project. AZoMining, viewed 21 November 2024, https://www.azomining.com/News.aspx?newsID=5097.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.